$33.46 -0.28 (-0.83%)
2/10/2012 4:01 PM

Medicis Pharmaceutical Corp (NYSE:MRX)

CAPS Rating: 3 out of 5

A specialty pharmaceutical company focused on the development and marketing of products in the United States for the treatment of dermatological, aesthetic and podiatric conditions.

Featured Broker Partners


Advertisement